Asia · Markets & Finance · SCMP Business

AstraZeneca, Merck, Novo deals boost Chinese biotech as global interest grows

Published by SCMP Business · Hong Kong 13 h ago

Shares of Akeso surged after British drug maker AstraZeneca moved to advance the Chinese biotech firm’s flagship cancer drug, while a new deal from US giant Merck further…

Read the full article on SCMP Business Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.scmp.com)

Also worth reading

CNBC-TV18

India's Inox Clean Energy files for $1 billion IPO

Business Standard

Tata stocks drop amid concerns over listing; Titan and TCS lead decline

The Straits Times Business

SGX CEO Loh Boon Chye’s pay rises 7% to $8.37m as exchange delivers standout year

Moneycontrol

Hrithik Roshan now worth Rs 2,500 Crore but once lived in bare home as father Rakesh Roshan struggled financially

The Edge Singapore

Canada’s economy shows third quarter slowdown after spring surge

Tech in Asia